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ABSTRACT: Obesity is a complex problem, associated 
with many diseases. Microarray gene expression data have 
been extensively used to detect differentially expressed 
(DE) genes and expression quantitative trait loci (eQTL), 
however, RNA-Sequencing data have the potential to reveal 
novel genes involved in complex traits. The objective was 
to elucidate biological pathways and potential biomarkers 
for obesity in a porcine model, by systems genetics 
approaches using RNA-Sequencing data. Previously, we 
created an F2 pig population which was deeply phenotyped 
and genotyped. Based on their degree of obesity, 36 
animals were selected for RNA-Sequencing.  Analysis 
included DE, pathway detection and eQTL mapping. We 
identified 198 DE genes, which could be divided in immune 
and developmental related processes. Furthermore, we 
revealed 761 cis-eQTLs of which several could be linked to 
obesity. Concluding, systems genetics analysis of RNA-Seq 
data elucidated biologically relevant pathways and potential 
genetic biomarkers affecting obesity. 
 
Introduction 
 
Obesity is a complex health problem, associated 
with several metabolic diseases. The exponential rise in the 
incidence of obesity worldwide, and its huge welfare, social 
and economic impact has enlarged the urge of gaining 
knowledge on the biologic and genetic background. Here, 
we use a porcine model for human obesity. It has been 
shown that the pig has similar metabolic, digestive and 
cardiovascular features, and it resembles humans more than 
rodents (Spurlock and Gabler (2008)). We previously 
created an F2 pig population, and revealed the potential of 
this population to study human obesity (Kogelman et al. 
(2013)).    
Currently, Next Generation Sequencing (NGS) 
technologies are offering a huge potential for studying 
complex traits and diseases. RNA-Sequencing (RNA-Seq) 
data is replacing microarray expression studies, because of 
their huge potential in e.g., more precise measurements of 
expression levels and the potential to discover novel 
transcripts (Wang et al. (2009)). Sequencing-based 
technologies have been shown to give promising results in 
e.g., kidney disease (Mimura et al. (2013)), and a huge 
potential is expected for other complex, multifactorial 
diseases and traits, such as obesity.   
To elucidate the biological and genetic background 
of complex diseases, several network approaches have been 
used to detect pathways and potential causal genes. 
Furthermore, previous studies have shown that studying 
expression quantitative trait loci (eQTLs) is an appropriate 
way of increasing the knowledge of complex diseases and 
traits (Morley et al. (2004), Kadarmideen et al. (2006)). In 
eQTL mapping each transcript abundance is treated as a 
phenotype and typical QTL mapping or GWAS approaches 
are applied to this expression phenotype or expression-trait 
(see Kadarmideen et al. (2006) for definitions).  
  The objective of this study was to increase the 
systematic understanding of the transcriptional (co-) 
regulations of obesity and related traits by detecting 
differentially expressed genes and eQTLs. This will result 
in the interpretation of the functions of known and novel 
genes associated with obesity, and increase the 
understanding of obesity-related biological pathways. 
 
Materials and Methods 
 
Experimental design. An F2 pig population was 
created using Danish production pig breeds (i.e. Yorkshire 
and Duroc sows) and Gӧttingen minipig boars. The 
production breeds are intensively selected for leanness and 
growth, while the Gӧttingen minipigs are prone to obesity 
and share metabolic impairments seen in obese humans 
(Johansen et al. (2001)). As published earlier, the F2 
population (454 pigs) was intensively phenotyped for, e.g. 
weight, body confirmation, DXA scanning, and slaughter 
characteristics (Kogelman et al. (2013)). All animals were 
genotyped using the Illumina Porcine 60K SNP Chip.   
  
Obesity Index. In animal breeding, multi-trait 
selection indexes are used to select animals based on 
estimated breeding values (EBVs) for several traits of 
interest (Cameron (1997)). Based on this, we created the 
Obesity Index (OI), by calculating selection index weights 
and combining EBVs for nine different obesity-related 
traits (reported in Kogelman et al. (2013)) into one 
aggregate total merit index for all animals. Traits selected 
for the obesity index were: weight and abdominal 
circumference at slaughter age, average daily gain, 
estimated fat mass and percentage of fat at DXA scanning, 
back fat thickness at position 1 and position 2, weight of 
leaf fat and weight of omental fat at slaughtering. This 
resulted in a single genetic OI score, with the potential to 
determine whether an animal was genetically obese or lean.   
 
RNA Sequencing. Based on the OI 36 (12 high, 
12 intermediate and 12 low OI) animals were selected for 
RNA-Seq. RNA-Seq was performed on the Illumina 
HiSeq2500 (AROS, Denmark), using subcutaneous fat 
tissue. Alignment was performed using STAR, resulting in 
(after quality control) approximately 30 million mapped 
reads per sample, mapped to 25,322 unique transcripts. 
After alignment, raw counts were normalized and corrected 
for gender.  
Differential expression. Differentially expressed 
(DE) transcripts for the OI were detected using a linear 
model, fitting the OI as continuous variable and gender as 
covariate using the R-package Limma (Smyth (2005)). 
Estimates were corrected for multiple testing using the 
Benjamini & Hochberg (FDR) correction. Transcripts were 
detected as significantly DE using an FDR < 0.05.  
 
Functional annotation. The associated genes at 
the DE transcripts were detected using BioMart (Durinck et 
al. (2005)). To identify overrepresented Gene Ontology 
(GO) terms and pathways we used the online available 
database GeneNetwork (http://www.genenetwork.nl), 
which is constructed using human, mouse and rate 
expression data. Gene functions were predicted against 
known pathways and gene sets in various biological 
databases. Overrepresentation of GO-terms and pathways 
was tested using the Mann-Whitney U test, and P-values 
were afterwards corrected for multiple testing using the 
Bonferroni correction. 
eQTL studies. eQTL mapping was performed to 
find the downstream effects of the genetic variants 
associated with obesity, by treating each transcript 
abundance as phenotype. RNA-Seq data was corrected for 
the gender effect, normalization was applied, and technical 
variation was checked using a principal component (PC) 
analysis on the RNA-Seq sample correlation matrix (Westra 
et al. (2013)). Cis-eQTLs were defined when the associated 
SNP was within 10 Mb of the transcript. This window was 
chosen based on preliminary results, the large haplotype 
block size of pigs (on average 400 Kb), and the knowledge 
that haplotype block sizes in F2 populations will be even 
larger. Only SNPs with a minor allele frequency of >0.05 
and a Hardy-Weinberg equilibrium P-value of >0.001 were 
included in the analyses. Associations were determined 
using Spearman's rank correlation and to correct for 
multiple testing, the analysis was repeated 10 times, each 
time permuting the sample labels, in order to retain the 
correlation structure within the genotype and gene-
expression data. The resultant p-value distribution was 
applied as a null-distribution to control the false discovery 
rate at 0.05. 
Results and Discussion 
 
Differential expression. We detected a total of 
189 DE genes (FDR<0.05), of which 139 were 
corresponding to unique genes.  
 
Table 1. Top 10 differentially expressed transcripts 
Transcript Expr. P-value  Assoc Gene  
ENSSSCG00000025188 22.01 1.8E-3 LEPR 
ENSSSCG00000028062 20.70 1.8E-3 TCEAL3 
ENSSSCG00000012566 23.63 3.3E-3  
ENSSSCG00000003341 25.65 4.3E-3 TAS1R3 
ENSSSCG00000007005 27.52 4.6E-3 CSGALNACT1 
ENSSSCG00000016093 24.62 7.3E-3  
ENSSSCG00000004177 32.19 7.6E-3 RPS12 
ENSSSCG00000022685 24.57 7.6E-3 ROM1 
ENSSSCG00000009060 24.96 1.9E-2 MAML3 
ENSSSCG00000016957 21.96 1.9E-2 CD180 
The most highly DE gene was the LEPR (Leptin 
Receptor) gene. Leptin is a hormone produced by adipose 
tissue and plays a key role in energy regulation and 
appetite. Dysfunctioning of the LEPR gene results in 
obesity in human and mouse models (Gilbert et al. (2003)). 
The TAS1R3 gene encodes a taste receptor. The perception 
of taste has been linked before to eating behavior (Grimm 
and Steinle (2011)) and therefore also associated with 
obesity. The RPS12 gene is encoding the Ribosomal 
Protein S12, which has been shown to be associated with 
diabetic nephropathy in African Americans (McDonough et 
al. (2001)). The MAML3 gene is encoding the mastermind-
like 3 protein, which has been associated with protein 
intake in a meta-analysis. However, it did not pass the 
significance threshold in the 2
nd
 stage (Tanaka et al. 
(2013)). The last gene in the top 10 DE genes is the CD180 
gene, previously called Ly64. This gene has been shown to 
be differentially expressed in the liver of mice, for a 
subphenotype of diabetes (Mir et al. (2003)). Moreover, it 
was also differentially expressed in mice showing diabetic 
development (Fornari et al. (2011)). Furthermore, we 
detected the RPL13A gene (P-value=0.02), of which 
disruption caused resistance to lipotoxity (Michel et al. 
(2011)) and the TNMD gene (P-value=0.02), previously 
associated with adiposity, glucose metabolism and in men 
also type 2 diabetes development (Tolppanen et al. (2007)).  
 
Functional annotation. A network was 
constructed using the GeneNetwork software on all DE 
genes.  
 
Figure 1. Network construction of DE genes, with the 
clustering of two subnetworks (blue and green). The 
intensity of the colors represents the significance of 
presence of the gene in the particular network structure.  
  
The constructed network of DE genes shows two 
clear clusters of highly interconnected genes. Those two 
clusters, or subnetworks, were separately analyzed using 
GeneNetwork.  
The first subnetwork (blue in Fig. 1) shows a 
strong association with immune related pathways. Highly 
significant GO terms in the Biological Processes are, for 
example, leukocyte migration (Padj=6.62E
-14
), interleukin-12 
production (Padj=7.45E
-14
) and cytokine production 
(Padj=7.50E
-14
). The most significant KEGG pathway is the 
chemokine signaling pathway (Padj=3.46E
-15
). This pathway 
has been associated with the inflammation response in 
obesity, and subsequent development of insulin resistance 
(Tsuguhito (2013)). Moreover, in the Mouse Genome 
Informatics (MGI) database an increased circulating tumor 
necrosis factor level (Padj=2.18E
-14
) was highly 
overrepresented, which has repeatedly shown to be 
associated with obesity-linked insulin resistance 
(Hotamisligil et al. (1993)).  
The second subnetwork (green in Fig. 1) showed a 
strong association with developmental associated pathways. 
The most highly overrepresented GO term in the Biological 
Processes was regulation of canonical Wnt receptor 
signaling pathway (Padj=1.05E
-11
), and the Wnt signaling 
pathway is also the most overrepresented KEGG pathway 
(Padj=2.78E
-6
). This pathway has a major role in the 
development of obesity, by generation of new adipocytes 
(adipogenesis) (Laudes (2011)).  
 
 eQTL study. Genome-wide genetic analyses of 
transcriptomic variation measured by RNA-Seq resulted in 
the detection of eQTLs. In total 761 cis-eQTLs were 
detected, considering all SNPs and transcripts (Fig. 2A).  
 
Figure 2. eQTL study results. The dotplot (A) shows the 
detected eQTLs with their SNP and transcript position. The 
boxplot (B) shows one of the highly significant eQTLs: the 
PEX10 gene.  
 
The PEX10 gene was one of the most significant 
eQTLs detected (Fig. 2B). This gene is involved in the 
import of peroxisomal matrix proteins, which has an 
important role in the breakdown of very long chain fatty 
acids (Chen et al. (2010).  
 
Future studies will include further investigation of 
the DE genes, for example, by investigating the up- and 
down-regulated genes. Moreover, as the eQTL approach 
does not take the family structure of the pigs into account, 
the eQTL findings will be validated using a linkage based 
method used in R/QTL. Finally, both DE and eQTL 
findings will be validated in human expression data.  
 
Conclusion 
 
We used systems genetics approaches, i.e. DE, 
functional annotation and eQTL studies, to elucidate the 
systems biological and genetic background of obesity and 
obesity-related diseases. In total 189 DE genes were 
detected and many could be linked to human obesity, 
emphasizing the validity of the pig as a model for human 
obesity. A network analyses on DE genes revealed two 
subnetworks of closely related genes; those subnetworks 
represent different kind of biological processes directly or 
indirectly related to obesity, e.g. immune related processes 
and developmental processes. Furthermore, the detection of 
various eQTLs gives us the opportunity to reveal whole-
genome regulatory mechanisms and potential causal genes 
for human obesity and obesity-related diseases.   
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